Pharma Journalist 8962 posts 0 comments

Immatics Biotechnologies announced that it has entered into a research collaboration and license agreement with Genmab A/S to develop next-generation, T-cell engaging bispecific…
Read More...

Genmab A/S announced that it has entered into a research collaboration and exclusive license agreement with privately owned Immatics Biotechnologies GmbH (Immatics), to discover and…
Read More...

Pfenex Inc. announced the receipt of a milestone payment from Merck associated with the initiation of the first Phase 3 clinical study of (V114), an investigational polyvalent conjugate…
Read More...

UL announced that together with Applied DNA Sciences Inc. they have joined forces to form a strategic partnership that will lay the foundation for a significant new development in…
Read More...

Otsuka Pharmaceutical and Visterra announce that they have entered into a definitive merger agreement pursuant to which Otsuka will acquire Visterra for approximately USD 430 million in…
Read More...

BioNTech AG and Genevant Sciences announced that they have entered into a collaboration to develop five mRNA therapeutic programs for rare diseases with high unmet medical need. The…
Read More...

CURE Pharmaceutical announced that it has signed a term sheet with Therapix Biosciences to acquire the non-pain assets of Therapix, subject to the completion of the related conditions.…
Read More...

AbbVie announced an update on a Phase 3 study (DBL3001) of ibrutinib (IMBRUVICA) in untreated (treatment-naïve) diffuse large B-cell lymphoma (DLBCL), an aggressive form of non-Hodgkin…
Read More...

Amphastar Pharmaceuticals announced business expansion plans for its subsidiary, Amphastar Nanjing Pharmaceuticals. To date, ANP has provided Active Pharmaceutical Ingredients and…
Read More...

Filament BioSolutions, a development-stage company focused on delivering innovative therapeutics for nutritional deficiencies, announced continued progress in the development of its…
Read More...